Crispr Therapeutics Ag (CRSP)

Capital Lease Obligations

$197.55M

Quarterly · Period ending: · USD

CRSP logo

CRSP Capital Lease Obligations

Latest reported$197.55M
CRSP Quarterly Capital Lease Obligations ($0.00 → $197.55M)
High-resolution chart · PNG

CRSP capital lease obligations history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Crispr Therapeutics Ag Capital Lease Obligations — Quarterly (USD)
Period endingCapital Lease Obligations (USD)
197,550,000
202,172,000
188,168,000
192,768,000
197,425,000
201,852,000
206,405,000
210,662,000
214,852,000
218,935,000
223,007,000
226,585,000
230,342,000
224,552,000
228,179,000
230,895,000
234,160,000
227,904,000
212,872,000
192,734,000
175,329,000
49,408,000
50,067,000
38,570,000
40,317,000
42,390,000
44,050,000
36,827,000
37,200,000
31,728,000
0
0
0
0
0
0
0
0
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.